文献

J-GLOBAL ID：201702218222177514   整理番号：17A0776736

トルバプタンは急性非代償性心不全患者の腎機能の悪化リスクを減少させ,左室駆出率を維持した - 前向き無作為比較研究 -

Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction - Prospective Randomized Controlled Study -

著者 (16件)： Tamaki Shunsuke (Division of Cardiology, Osaka General Medical Center) ,  Sato Yoshihiro (Division of Cardiology, Osaka General Medical Center) ,  Yamada Takahisa (Division of Cardiology, Osaka General Medical Center) ,  Morita Takashi (Division of Cardiology, Osaka General Medical Center) ,  Furukawa Yoshio (Division of Cardiology, Osaka General Medical Center) ,  Iwasaki Yusuke (Division of Cardiology, Osaka General Medical Center) ,  Kawasaki Masato (Division of Cardiology, Osaka General Medical Center) ,  Kikuchi Atsushi (Division of Cardiology, Osaka General Medical Center) ,  Kondo Takumi (Division of Cardiology, Osaka General Medical Center) ,  Ozaki Tatsuhisa (Division of Cardiology, Osaka General Medical Center) ,  Seo Masahiro (Division of Cardiology, Osaka General Medical Center) ,  Ikeda Iyo (Division of Cardiology, Osaka General Medical Center) ,  Fukuhara Eiji (Division of Cardiology, Osaka General Medical Center) ,  Abe Makoto (Division of Cardiology, Osaka General Medical Center) ,  Nakamura Jun (Division of Cardiology, Osaka General Medical Center) ,  Fukunami Masatake (Division of Cardiology, Osaka General Medical Center)
資料名： Circulation Journal  (Circulation Journal)
巻： 81  号： 5  ページ： 740-747(J-STAGE)  発行年： 2017年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:急性非代償性心不全(ADHF)治療の頼みの綱が利尿療法...

シソーラス用語： *利尿薬 ,...
準シソーラス用語： *急性非代償性心不全 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0776736&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者キーワード (3件)： Acute decompensated heart failure ,  Diuretics ,  Renal function

分類 (3件)： 泌尿生殖器の臨床医学一般  (GM01030E) ,  循環系疾患の薬物療法  (GJ05020M) ,  泌尿器作用薬の臨床への応用  (GW11020C)

物質索引 (2件)： トルバプタン ,  クレアチニン

引用文献 (39件)：

• 1. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, Committee ASA, et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: Findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007; 153: 1021-1028.
• 2. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE registry. Cardiology 2009; 113: 12-19.
• 3. Felker GM, O’Connor CM, Braunwald E; Heart Failure Clinical Research Network I. Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil? Circ Heart Fail 2009; 2: 56-62.
• 4. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-338.
• 5. Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67.

タイトルに関連する用語 (8件)： トルバプタン ,  急性非代償性心不全 ,  患者 ,  腎機能 ,  悪化 ,  リスク ,  左室駆出率 ,  研究